Answers are grounded in this paper and cite their sources.
The X-ray crystal structure of 28- O -methylrapamycin 2 bound to FKBP12 is described. This rapamycin analogue binds to FKBP12 with an affinity comparable to that of rapamycin, but its immunosupressive activity is reduced by a factor of 1000. The atomic structure of the complex formed by FKBP12 and 28- O -methylrapamycin is compared with those of the FKBP12−rapamycin and FKBP12−FK506 complexes. The steric 28- O -methyl group induces a dramatic shift in the orientation of the cyclohexyl moiety, which is now in a position similar to the one observed for the cyclohexyl subunit in the FKBP12−FK506 complex. The conformation of the macrocyclic part of the molecule remains unchanged. As a consequence of 28- O -methylation and the resulting modified orientation taken by the cyclohexyl subunit, two intermolecular hydrogen bonds between the ligand and the binding protein are lost in comparison to the FKBP12−rapamycin complex. The affinity for FKBP12 is not significantly affected by these structural changes, but the immunosuppressive activity is greatly reduced, suggesting a critical role for the cyclohexyl ring in the interaction of the FKBP12−rapamycin complex with its molecular target.
No takes yet. Share an insight, caveat, or question.
Kallen et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: